Innoviva (INVA) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Innoviva (INVA) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Innoviva |
1.69 Bn |
1.08 Bn |
75.83 Mn |
128.31% |
| Date | Value |
|---|
| Mar 31, 2026 |
128.31% |
| Dec 31, 2025 |
109.14% |
| Sep 30, 2025 |
110.04% |
| Jun 30, 2025 |
36.84% |
| Mar 31, 2025 |
36.24% |
| Dec 31, 2024 |
249.89% |
| Sep 30, 2024 |
231.01% |
| Jun 30, 2024 |
182.20% |
| Mar 31, 2024 |
138.11% |
| Dec 31, 2023 |
158.38% |
| Sep 30, 2023 |
121.99% |
| Jun 30, 2023 |
63.26% |
| Mar 31, 2023 |
62.43% |
| Dec 31, 2022 |
72.71% |
| Sep 30, 2022 |
90.15% |
| Jun 30, 2022 |
8.97% |
| Mar 31, 2022 |
8.87% |
| Dec 31, 2021 |
-57.83% |
| Sep 30, 2021 |
-55.74% |
| Jun 30, 2021 |
-53.17% |
